Saturday Dec 5 | WebWire
Abbott's Ibis Technology Named One of the Top Innovations for 2009 by The Scientist
Abbott Park, Illinois - Abbott's Ibis technology for detecting and characterizing a vast array of microorganisms has been named one of the top innovations in 2009 by The Scientist magazine.
Tests of Abbott's drug-coated stents show positive results
Abbott Laboratories ' experimental dissolvable heart stent effectively treated heart disease and absorbed into the walls of patients' arteries with no clots reported after three years, paving the way for broader studies of the next-generation device by year-end, the company said.
5-Star Stocks Poised to Pop: Abbott Labs
Based on the aggregated intelligence of 145,000-plus investors participating in Motley Fool CAPS , the Fool's free investing community, health-care company Abbott Labs has earned a coveted five-star ranking .
Abbott settles patent suit over TriCor
Abbott Laboratories said Teva Pharmaceutical Industries Ltd. won't sell the 145-milligram version of Abbott's TriCor cholesterol-lowering drug until at least 2011 under a patent-infringement lawsuit settlement.
In the decade that Miles White has headed Abbott Laboratories , the healthcare and pharmaceuticals giant has done more than $30 billion worth of deals, greatly expanding its offering of drugs, nutritional products, medical devices and diagnostic equipment.
Chasing Value: Ten stocks for 2010 -- Part 5
Filed under: Microsoft , Abbott Laboratories , Chasing Value , Stocks to Buy The march toward year end continues as three more stocks are reviewed in a search for the eventual 2010 stock picks.
Abbott's diet drug's risks have FDA's attention
"The analysis of these data is ongoing and FDA is making no conclusions about the preliminary findings at this time," the agency said in a statement.
Abbott Laboratories Reports Positive Results on Niaspan
Abbott Laboratories announced on Monday positive results of cholesterol drug Niaspan.
Abbott's Niaspan Works Better Than Merck's Zetia in Artery Clearing Study
A finding that Merck & Co.a s cholesterol pills Vytorin and Zetia didna t reopen clogged arteries as well as Abbott Laboratories a Niaspan has set off a medical debate on heart treatment strategies.
Abbott Labs Is Making the Right Moves
Wedbush Pac Grow initiated coverage of the health-care firm at Outperform. Abbott Laboratories By Wedbush Pac Grow Life Sciences WE ARE INITIATING COVERAGE of Abbott Laboratories with an Outperform rating.
Abbott under kickback probe over Depakote sales
Abbott Laboratories this morning confirmed the company's sales and marketing practices of Depakote, the widely used drug to treat bipolar disorder and epilepsy, are under federal investigation.
Abbott's $1.67 Billion Patent-Suit Loss to J&J Over Humira Upheld By Judge
Abbott Laboratories failed to convince a federal judge to throw out a record $1.67 billion verdict won by Johnson & Johnsona s Centocor unit in a suit over an arthritis drug patent.
Crain's Chicago Business Weekly Edition
29 | Founder, CEO | Groupon Inc. | Chicago For someone with a life goal no less lofty than "changing the world," Andrew Mason doesn't seem to take himself too seriously. When he found out that his company, Groupon, was up against Abbott Laboratories for a Chicago Innovation people's choice award, ...
Scam victims left to pick up pieces after losing everything
In 2001, Lillie Greene's life was turned upside down. Her son, not knowing he was diabetic, suffered an aneurysm and went into a coma for 32 days.
Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois
Abbott Park, Illinois - Abbott announced today that it has received the annual Illinois Continuous Improvement Award for environmental excellence.
Impax Laboratories initiates patent challenge for TRICOR
Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed by Abbott Laboratories in connection with its TRICORA tablets, 48 mg and 145 mg.
Jensen Fund Bets on Abbott, Adobe
Rob McIver, co-manager of the Jensen Fund , says long-term investing success means selecting high-quality securities, such as Abbott Laboratories and Adobe .
Abbott opens new R&D center at U of I
Abbott Laboratories has opened its Abbott Nutrition facility at the Research Park on the University of Illinois campus.
SADIF Analytics releases new summary due diligence report for Abbott Laboratories
Ilhavo, Portugal a ' 20/10/2009 a ' SADIF Investment Analytics, announces a new summary due diligence report covering Abbott Laboratories .
Baxter and Abbott Refuse to Be Toppled by Foreign Currency Headwinds, an Industrial Info News Alert
Global pharmaceutical companies Baxter International Incorporated : and Abbott Laboratories : this week reported earnings for the third quarter of their 2009 fiscal years.
Also on Topix